Involvement of BID translocation in glycyrrhetinic acid and 11-deoxy glycyrrhetinic acid-induced attenuation of gastric cancer growth

Nutrition and Cancer

Volumn 66, Issue 3, 2014, Pages 463-473

  Lin, Dejian ^a   Zhong, Wei ^a   Li, Juan ^a   Zhang, Bing ^a   Song, Gang ^a   Hu, Tianhui ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

11 DEOXY GLYCYRRHETINIC ACID; ANTINEOPLASTIC AGENT; BETA TUBULIN; CELL CYCLE PROTEIN 20; CHAPERONIN 60; CYCLIN B1; CYTOCHROME C; GLYCYRRHETINIC ACID; GLYCYRRHETINIC ACID DERIVATIVE; LAMIN B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BID; PROTEIN P21; UNCLASSIFIED DRUG; 11-DEOXY GLYCYRRHETINIC ACID; BID PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DOWN REGULATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER PROTECTION; METASTASIS INHIBITION; MITOCHONDRION; MOUSE; MTT ASSAY; NONHUMAN; S PHASE CELL CYCLE CHECKPOINT; STOMACH CARCINOMA; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CELL CYCLE G2 PHASE; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; METABOLISM; NUDE MOUSE; PATHOLOGY; PROTEIN TRANSPORT; STOMACH NEOPLASMS; TUMOR CELL LINE;

GLYCYRRHIZA; MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; G2 PHASE; GLYCYRRHETINIC ACID; HUMANS; MICE, NUDE; PROTEIN TRANSPORT; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84897376193     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.877498     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108, 2005.
2. Zheng L, Wang L, Ajani J, and Xie K: Molecular basis of gastric cancer development and progression. Gastric Cancer 7, 61-77, 2004. (Pubitemid 38899656)
3. Xie K, Wei D, and Huang S: Transcriptional anti-angiogenesis therapy of human pancreatic cancer. Cytokine Growth Factor Rev 17, 147-156, 2006. (Pubitemid 43816895)
4. Liu D, Song D, Guo G, Wang R, Lv J, et al.: The synthesis of 18 betaglycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells. Bioorg Med Chem 15, 5432-5439, 2007. (Pubitemid 46962999)
5. Luk JM, Zhang QS, Lee NP, Wo JY, Leung PP, et al.: Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model. Liver Int 27, 548-557, 2007. (Pubitemid 46534577)
6. Asl MN, and Hosseinzadeh H: Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22, 709-724, 2008. (Pubitemid 351955567)
7. Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, et al.: Antiviral effects of Glycyrrhiza species. Phytother Res 22, 141-148, 2008. (Pubitemid 351363230)
8. Makino T, Ohtake N, Watanabe A, Tsuchiya N, Imamura S, et al.: Downregulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury. Drug Metab Dispos 36, 1438-1443, 2008. (Pubitemid 351929327)
9. Beseda I, Czollner L, Shah PS, Khunt R, Gaware R, et al.: Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases. Bioorg Med Chem 18, 433-454, 2000.
10. Baltina LA: Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr Med Chem 10, 155-171, 2003. (Pubitemid 36131651)
11. Ko BS, Jang JS, Hong SM, Sung SR, Lee JE, et al.: Changes in components, glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis Fisch, modify insulin sensitizing and insulinotropic actions. Biosci Biotechnol Biochem 71, 1452-1461, 2007. (Pubitemid 47012031)
12. Yin XM: Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369, 7-19, 2006.
13. Sarig R, Zaltsman Y, Marcellus RC, Flavell R, Mak TW, et al.: BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts. J Biol Chem 278, 10707-10715, 2003. (Pubitemid 36800341)
14. Valentijn AJ, and Gilmore AP: Translocation of full-length Bid to mitochondria during anoikis. J Biol Chem 279, 32848-32857, 2004. (Pubitemid 39014745)
15. Song G, Chen GG, Chau DK, Miao J, and Lai PBS: Bid exhibits S phase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in hepatocellular carcinoma cells. Apoptosis 13, 693-701, 2008.
16. Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, et al.: A role for proapoptotic BID in the DNA-damage response. Cell 122, 579-591, 2005. (Pubitemid 41191156)
17. Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, et al.: Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122, 593-603, 2005. (Pubitemid 41191157)
18. Song G, Chen GG, Hu TH, and Lai PBS: Bid stands at the crossroad of stress-response pathways. CurrentCancer Drug Targets 10, 584-592, 2010.
19. Song G, Chen GG, Yun JP, and Lai PBS.: Association of p53 with Bid induces cell death in response to etoposide treatment in hepatocellular carcinoma. Current Cancer Drug Targets 9, 871-880, 2009.
20. Song G, Mao YB, Cai QF, Yao LM, Ouyang GL, et al.: Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis via activating p53 and regulating apoptosis-related proteins. Braz J Med Biol Res 38, 1791-1798, 2005. (Pubitemid 43078608)
21. Song G, Ouyang G, Mao YB, Ming YL, Bao S, et al.: Osteopontin promotes metastatic growth of gastric cancer by augmenting cell survival and invasion through Akt-mediated HIF-1α up-regulation and MMP9 activation. J Cell Mol Med 13, 1706-1718, 2009.
22. Satomi Y, Nishino H, and Shibata S: Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2. Anticancer Res 25, 4043-4047, 2005. (Pubitemid 41665183)
23. Luo HL, Zhang ZL,Wu QN, HuangMS, HuangW, et al.: 18-glycyrrhetinic Acid-induced Apoptosis and Relation with Intracellular Ca 2+ Release in Human Breast Carcinoma Cells. Chinese-German J Clin Oncol 3, 137-140, 2004.
24. Song D, Gao Y, Wang R, Liu D, Zhao L, et al.: Downregulation of c-FLIP, XIAP and Mcl-1 protein as well as depletion of reduced glutathione contribute to the apoptosis induction of glycyrrhetinic acid derivatives in leukemia cells. Cancer Biol Ther 9, 96-108, 2010.
25. Wang ZY and Nixon DW: Licorice and cancer. Nutr Cancer 39, 1-11, 2001. (Pubitemid 32880942)
26. Popovich DG, Yeo SY, and Zhang W: Ginseng (Panax quinquefolius) and Licorice (Glycyrrhiza uralensis) Root Extract Combinations Increase Hepatocarcinoma Cell (Hep-G2) Viability. Evid Based Complement Alternat Med 2011, 2011:408273. doi: 10.1093/ecam/nep074. Epub, 2011.
27. Hawthorne S and Gallagher S: Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells. J Pharm Pharmacol 60, 661-666, 2008. (Pubitemid 351589055)
28. Rabbitt EH, Lavery GG, Walker EA, Cooper MS, Stewart PM, et al.: Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation. FASEB J 16, 36-44, 2002. (Pubitemid 34027948)
29. Gandhi NM, Maurya DK, Salvi V, Kapoor S, Mukherjee T, et al.: Radioprotection of DNA by glycyrrhizic acid through scavenging free radicals. J Radiat Res 45, 461-468, 2004. (Pubitemid 40254076)
30. Miao J, Chen GG, Chun SY, Chak EC, and Lai PB: Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma. Int JOncol 25, 651-659, 2004.
31. Breitschopf K, Zeiher AM, and Dimmeler S: Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. J Biol Chem 275, 21648-21652, 2000. (Pubitemid 30481872)
32. K̈onig HG, Rehm M, Gudorf D, Krajewski S, Gross A, et al.: Full length Bid is sufficient to induce apoptosis of cultured rat hippocampal neurons. BMC Cell Biol 8, 7, 2007.